Patent US4039681A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4039681A Expired / Lapsed US ⏱️ 0.0 years remaining

Zinc methionine complex for acne treatment

Assignee: Zinpro Corp
•
Filing: 1976-02-23
•
Granted: 1977-08-02
•
Expires: 1996-02-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel pharmaceutical compositions containing 1:1 zinc methionine complex salts having the formula: [CH.sub.3 SCH.sub.2 CH.sub.2 CH(NH.sub.2)COO.sup.. Zn.sup.+.sup.+].sub.w X wherein X is an anion and w is an integer equal to the anionic charge of X. These compounds when administered in dosage form have been found to have therapeutic effect in the treatment of certain epidermal disorders such as acne.

Inventors

  • 👤 Mahmoud M. Abdel-Monem

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 02:34
CPC Classifications
A; A23; A23K; A23K20/00; A23K20/20; A23K20/30; A23K20/10; A23K20/142

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 67 words
A composition for treating acne comprising a pharmaceutically acceptable carrier and a small but pharmaceutically effective acne alleviating amount of a 1:1 zinc methionine complexed salt of the formula: [CH.sub.3 SCH.sub.2 CH.sub.2 CH(NH.sub.2)COO.Zn.sup.+.sup.+].sub.w X wherein X is a non-toxic anion which has no inhibiting effect on the therapeutic effectiveness of said 1:1 zinc methionine complex, and W is an integer equal to the anionic charge of X.
Claim 2
Dependent Claim 67 words
A composition for treating acne comprising a pharmaceutically acceptable carrier and a small but pharmaceutically effective acne alleviating amount of a 1:1 zinc methionine complexed salt of the formula: [CH.sub.3 SCH.sub.2 CH.sub.2 CH(NH.sub.2)COO.Zn.sup.+.sup.+].sub.w X wherein X is a non-toxic anion which has no inhibiting effect on the therapeutic effectiveness of said 1:1 zinc methionine complex, and W is an integer equal to the anionic charge of X.
Claim 3
Dependent Claim 12 words
The composition of claim 1 wherein said anion is an inorganic anion.
Claim 4
Dependent Claim 14 words
The composition of claim 2 wherein said compound is 1:1 zinc methionine acid sulfate.
Claim 5
Dependent Claim 30 words
The composition of claim 2 wherein said composition is in dosage form, with each dosage containing from about 50 milligrams to about 1500 milligrams of said 1:1 zinc methionine complex.
Claim 6
Dependent Claim 24 words
The composition of claim 4 wherein the dosage form of said 1:1 zinc methionine complex contains from about 100 milligrams to about 250 milligrams.
Claim 7
Dependent Claim 15 words
The composition of claim 4 wherein said carrier is an orally administrable liquid pharmaceutical carrier.
Claim 8
Dependent Claim 17 words
The composition of claim 4 wherein said carrier is an orally administrable water soluble solid pharmaceutical carrier.
Claim 9
Independent Claim 83 words
A method of treating acne in a patient in need thereof which comprises orally administering to said patient a unit dosage of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a small but pharmaceutically effective acne alleviating amount of a 1:1 zinc methionine complex having the formula: [CH.sub.3 SCH.sub.2 CH.sub.2 CH(NH.sub.2)COO.Zn.sup.+.sup.+].sub.w X wherein X is a non-toxic inorganic anion inert to the pharmaceutical activity of the 1:1 zinc methionine complex and W is an integer equal to the anionic charge of X.
Claim 10
Independent Claim 83 words
A method of treating acne in a patient in need thereof which comprises orally administering to said patient a unit dosage of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a small but pharmaceutically effective acne alleviating amount of a 1:1 zinc methionine complex having the formula: [CH.sub.3 SCH.sub.2 CH.sub.2 CH(NH.sub.2)COO.Zn.sup.+.sup.+].sub.w X wherein X is a non-toxic inorganic anion inert to the pharmaceutical activity of the 1:1 zinc methionine complex and W is an integer equal to the anionic charge of X.
Claim 11
Dependent Claim 16 words
The method of claim 8 wherein said 1:1 zinc methionine complex is zinc methionine acid sulfate.
Claim 12
Dependent Claim 15 words
The method of claim 8 wherein said 1:1 zinc methionine complex is zinc methionine chloride.

References Cited (Backward Citations)

GB1029200A Cited
US3647834A Cited
DE2013426A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-08-01 1981-01-31 1981-08-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-08-01 1985-01-31 1985-08-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-08-01 1989-01-31 1989-08-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag